Discovery of Ligands for the TNFR1 Extracellular Domain Using Fragment‐Based Drug Discovery
ChemMedChem · 14.07.2026 · 21 (13)
DOI: 10.1002/cmdc.70365 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 03.07.2026. Verfasst von Henri Chédotal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Technical University of Denmark, Kgs. Lyngby, Denmark. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type I, Drug Discovery, Small Molecule Libraries. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danmarks Frie Forskningsfond, Villum Fonden, Novo Nordisk Fonden.
Abstract (Originalsprache)
Tumor necrosis factor receptor 1 (TNFR1) plays a major role in immunoregulation. It is involved in inflammatory and autoimmune diseases like rheumatoid arthritis, psoriasis, Alzheimer’s disease, and multiple sclerosis. However, few small‐molecule inhibitors of TNFR1 have been reported, even though they constitute a good alternative to already existing antibody therapies targeting the TNF pathway. Here, we report the discovery of a new class of molecules for the extracellular domain of TNFR1 using a fragment‐based approach through primary screening by NMR spectroscopy, followed by orthogonal validation by surface plasmon resonance (SPR) and X‐ray crystallography. Guided by these results, we have synthesized 46 analogs with micromolar potency showing up to ∼10‐fold improved affinity toward TNFR1 compared to the fragment hits. These results can provide a structural basis for the discovery of novel TNFR1 inhibitors in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Technical University of Denmark, Kgs. Lyngby, Denmark.
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Henri Chédotal, Anders Bach, Mads H Clausen
Förderung
- Danmarks Frie Forskningsfond
- Villum Fonden
- Novo Nordisk Fonden
- Carlsbergfondet
- Vetenskapsrådet
- VINNOVA
- Svenska Forskningsrådet Formas
Zitieren
APA
Chédotal, H., Povlsen, K., Narayanan, D., Gotfredsen, C. H., Gajhede, M., Bach, A., & Clausen, M. H. (2026). Discovery of Ligands for the TNFR1 Extracellular Domain Using Fragment‐Based Drug Discovery. ChemMedChem, 21(13). https://doi.org/10.1002/cmdc.70365
Vancouver
Chédotal H, Povlsen K, Narayanan D, Gotfredsen CH, Gajhede M, Bach A, et al. Discovery of Ligands for the TNFR1 Extracellular Domain Using Fragment‐Based Drug Discovery. ChemMedChem. 2026;21(13). doi:10.1002/cmdc.70365
BibTeX
@article{Chdotal2026,
author = {Chédotal, Henri and Povlsen, Katrine and Narayanan, Dilip and Gotfredsen, Charlotte H and Gajhede, Michael and Bach, Anders and Clausen, Mads H},
title = {Discovery of Ligands for the TNFR1 Extracellular Domain Using Fragment‐Based Drug Discovery},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {13},
doi = {10.1002/cmdc.70365}
}
EUVIMED